Intervention Protocol

Melatonin for non-respiratory sleep disorders in children with neurodevelopmental disorders

  1. Sohil Khan1,*,
  2. Helen Heussler2,3,
  3. Treasure McGuire1,4,5,
  4. Carolyn Dakin2,
  5. David Pache1,5,6,
  6. David Cooper2,3,
  7. Ross Norris1,7,8,
  8. Vicki Flenady9,
  9. Bruce Charles1

Editorial Group: Cochrane Developmental, Psychosocial and Learning Problems Group

Published Online: 11 MAY 2011

DOI: 10.1002/14651858.CD009140


How to Cite

Khan S, Heussler H, McGuire T, Dakin C, Pache D, Cooper D, Norris R, Flenady V, Charles B. Melatonin for non-respiratory sleep disorders in children with neurodevelopmental disorders (Protocol). Cochrane Database of Systematic Reviews 2011, Issue 5. Art. No.: CD009140. DOI: 10.1002/14651858.CD009140.

Author Information

  1. 1

    The University of Queensland, School of Pharmacy, Brisbane, Queensland, Australia

  2. 2

    Mater Children's Hospital, Department of Respiratory and Sleep Medicine, South Brisbane, Australia

  3. 3

    The University of Queensland, School of Medicine, Brisbane, Australia

  4. 4

    Bond University, Faculty of Health Sciences and Medicine, Gold Coast, Queensland, Australia

  5. 5

    Mater Health Services, Pharmacy (Practice & Development), South Brisbane, Australia

  6. 6

    Queensland University of Technology, School of Nursing and Midwifery, Brisbane, Australia

  7. 7

    Mater Pharmacy Services Hospital, Australian Centre for Paediatric Pharmacokinetics and Therapeutic Advisory Service, South Brisbane, QLD, Australia

  8. 8

    Griffith University, Gold Coast, Australia

  9. 9

    Mater Health Services, Translating Research Into Practice (TRIP) Centre - Mater Medical Research Institute, Woolloongabba, Queensland, Australia

*Sohil Khan, School of Pharmacy, The University of Queensland, Brisbane, Queensland, 4102, Australia. sohailkhan1981@gmail.com. sohailkhan1981@rediffmail.com.

Publication History

  1. Publication Status: New
  2. Published Online: 11 MAY 2011

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the role of melatonin for non-respiratory sleep disorders in children with neurodevelopmental disorders for improvement in sleep initiation, sleep maintenance and sleep scheduling when compared with either placebo, other medication for sleep disorders, psychological/behavioural treatment, light therapy or no treatment.